Clinical Trial Update: Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of Lanreotide Autogel 120 mg for symptoms in inoperable malignant intestinal obstruction completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Obstruction

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Intestinal Obstruction | Phase 2 | Status: COMPLETED | Results posted: 2019-04-01